Title : BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis.

Pub. Date : 2022 Apr

PMID : 34764434






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We aimed to evaluate the prognostic value of BCL2 expression determined by immunohistochemistry (IHC), incorporating both the staining intensity and proportion, in patients with de novo DLBCL who received rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) as first-line treatment. Prednisone DNA damage inducible transcript 3 Homo sapiens